Skip to main content
PMC home page
The Ulster Medical Journal logoLink to The Ulster Medical Journal
. 1998 Nov;67(2):79–90.

Ulster says 'NO'; explosion, resistance and tolerance. Nitric oxide and the actions of organic nitrates.

G D Johnston 1
PMCID: PMC2448994  PMID: 9885543

Full text

PDF
79

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams J. Nitrate tolerance and dependence. Am Heart J. 1980 Jan;99(1):113–123. doi: 10.1016/0002-8703(80)90321-x. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. J. Nitric oxide and airways. Eur Respir J. 1993 Feb;6(2):163–165. [PubMed] [Google Scholar]
  3. Bloch K. D., Wolfram J. R., Brown D. M., Roberts J. D., Jr, Zapol D. G., Lepore J. J., Filippov G., Thomas J. E., Jacob H. J., Bloch D. B. Three members of the nitric oxide synthase II gene family (NOS2A, NOS2B, and NOS2C) colocalize to human chromosome 17. Genomics. 1995 Jun 10;27(3):526–530. doi: 10.1006/geno.1995.1086. [DOI] [PubMed] [Google Scholar]
  4. Bruce I. N., Harris C. M., Nugent A., McDermott B. J., Johnston G. D., Bell A. L. Enhanced endothelium-dependent vasodilator responses in patients with systemic vasculitis. Scand J Rheumatol. 1997;26(4):318–324. [PubMed] [Google Scholar]
  5. Bucala R., Tracey K. J., Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest. 1991 Feb;87(2):432–438. doi: 10.1172/JCI115014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Burnett A. L., Lowenstein C. J., Bredt D. S., Chang T. S., Snyder S. H. Nitric oxide: a physiologic mediator of penile erection. Science. 1992 Jul 17;257(5068):401–403. doi: 10.1126/science.1378650. [DOI] [PubMed] [Google Scholar]
  7. Calver A., Collier J., Vallance P. Nitric oxide and cardiovascular control. Exp Physiol. 1993 May;78(3):303–326. doi: 10.1113/expphysiol.1993.sp003687. [DOI] [PubMed] [Google Scholar]
  8. Capron L., Jarnet J., Kazandjian S., Housset E. Growth-promoting effects of diabetes and insulin on arteries. An in vivo study of rat aorta. Diabetes. 1986 Sep;35(9):973–978. doi: 10.2337/diab.35.9.973. [DOI] [PubMed] [Google Scholar]
  9. Chakravarthy U., Stitt A. W., McNally J., Bailie J. R., Hoey E. M., Duprex P. Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes. Curr Eye Res. 1995 Apr;14(4):285–294. doi: 10.3109/02713689509033528. [DOI] [PubMed] [Google Scholar]
  10. Collier A., Wilson R., Bradley H., Thomson J. A., Small M. Free radical activity in type 2 diabetes. Diabet Med. 1990 Jan;7(1):27–30. doi: 10.1111/j.1464-5491.1990.tb01302.x. [DOI] [PubMed] [Google Scholar]
  11. Cowan J. C., Bourke J. P., Reid D. S., Julian D. G. Prevention of tolerance to nitroglycerin patches by overnight removal. Am J Cardiol. 1987 Aug 1;60(4):271–275. doi: 10.1016/0002-9149(87)90226-8. [DOI] [PubMed] [Google Scholar]
  12. DeMots H., Glasser S. P. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Cardiol. 1989 Mar 15;13(4):786–795. doi: 10.1016/0735-1097(89)90216-7. [DOI] [PubMed] [Google Scholar]
  13. Desai K. M., Sessa W. C., Vane J. R. Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid. Nature. 1991 Jun 6;351(6326):477–479. doi: 10.1038/351477a0. [DOI] [PubMed] [Google Scholar]
  14. DiCorleto P. E. Cellular mechanisms of atherogenesis. Am J Hypertens. 1993 Nov;6(11 Pt 2):314S–318S. [PubMed] [Google Scholar]
  15. Drexler H., Fischell T. A., Pinto F. J., Chenzbraun A., Botas J., Cooke J. P., Alderman E. L. Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology. Circulation. 1994 Apr;89(4):1615–1623. doi: 10.1161/01.cir.89.4.1615. [DOI] [PubMed] [Google Scholar]
  16. Drexler H., Hayoz D., Münzel T., Hornig B., Just H., Brunner H. R., Zelis R. Endothelial function in chronic congestive heart failure. Am J Cardiol. 1992 Jun 15;69(19):1596–1601. doi: 10.1016/0002-9149(92)90710-g. [DOI] [PubMed] [Google Scholar]
  17. Drexler H., Zeiher A. M., Meinzer K., Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 1991 Dec 21;338(8782-8783):1546–1550. doi: 10.1016/0140-6736(91)92372-9. [DOI] [PubMed] [Google Scholar]
  18. Egashira K., Hirooka Y., Kuga T., Mohri M., Takeshita A. Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms. Circulation. 1996 Jul 15;94(2):130–134. doi: 10.1161/01.cir.94.2.130. [DOI] [PubMed] [Google Scholar]
  19. Feelisch M., Noack E. A. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol. 1987 Jul 2;139(1):19–30. doi: 10.1016/0014-2999(87)90493-6. [DOI] [PubMed] [Google Scholar]
  20. Flavahan N. A. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation. 1992 May;85(5):1927–1938. doi: 10.1161/01.cir.85.5.1927. [DOI] [PubMed] [Google Scholar]
  21. Fung H. L., Chong S., Kowaluk E., Hough K., Kakemi M. Mechanisms for the pharmacologic interaction of organic nitrates with thiols. Existence of an extracellular pathway for the reversal of nitrate vascular tolerance by N-acetylcysteine. J Pharmacol Exp Ther. 1988 May;245(2):524–530. [PubMed] [Google Scholar]
  22. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373–376. doi: 10.1038/288373a0. [DOI] [PubMed] [Google Scholar]
  23. Gilcrease M. Z., Hoover R. L. Examination of monocyte adherence to endothelium under hyperglycemic conditions. Am J Pathol. 1991 Nov;139(5):1089–1097. [PMC free article] [PubMed] [Google Scholar]
  24. Gilligan D. M., Guetta V., Panza J. A., García C. E., Quyyumi A. A., Cannon R. O., 3rd Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation. 1994 Jul;90(1):35–41. doi: 10.1161/01.cir.90.1.35. [DOI] [PubMed] [Google Scholar]
  25. Gordon D., Reidy M. A., Benditt E. P., Schwartz S. M. Cell proliferation in human coronary arteries. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4600–4604. doi: 10.1073/pnas.87.12.4600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Gross S. S., Levi R. Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem. 1992 Dec 25;267(36):25722–25729. [PubMed] [Google Scholar]
  27. Guerra R., Jr, Brotherton A. F., Goodwin P. J., Clark C. R., Armstrong M. L., Harrison D. G. Mechanisms of abnormal endothelium-dependent vascular relaxation in atherosclerosis: implications for altered autocrine and paracrine functions of EDRF. Blood Vessels. 1989;26(5):300–314. doi: 10.1159/000158779. [DOI] [PubMed] [Google Scholar]
  28. Henderson A. H. St Cyres lecture. Endothelium in control. Br Heart J. 1991 Mar;65(3):116–125. doi: 10.1136/hrt.65.3.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hibbs J. B., Jr Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activity. Res Immunol. 1991 Sep;142(7):565–598. doi: 10.1016/0923-2494(91)90103-p. [DOI] [PubMed] [Google Scholar]
  30. Higenbottam T. Inhaled nitric oxide: a magic bullet? Q J Med. 1993 Sep;86(9):555–558. [PubMed] [Google Scholar]
  31. Hunt J. V., Smith C. C., Wolff S. P. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes. 1990 Nov;39(11):1420–1424. doi: 10.2337/diab.39.11.1420. [DOI] [PubMed] [Google Scholar]
  32. Ignarro L. J., Lippton H., Edwards J. C., Baricos W. H., Hyman A. L., Kadowitz P. J., Gruetter C. A. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981 Sep;218(3):739–749. [PubMed] [Google Scholar]
  33. Jugdutt B. I. Intravenous nitroglycerin unloading in acute myocardial infarction. Am J Cardiol. 1991 Nov 18;68(14):52D–63D. doi: 10.1016/0002-9149(91)90261-i. [DOI] [PubMed] [Google Scholar]
  34. Jugdutt B. I. Nitrates in myocardial infarction. Cardiovasc Drugs Ther. 1994 Aug;8(4):635–646. doi: 10.1007/BF00877417. [DOI] [PubMed] [Google Scholar]
  35. Jugdutt B. I., Sussex B. A., Warnica J. W., Rossall R. E. Persistent reduction in left ventricular asynergy in patients with acute myocardial infarction by intravenous infusion of nitroglycerin. Circulation. 1983 Dec;68(6):1264–1273. doi: 10.1161/01.cir.68.6.1264. [DOI] [PubMed] [Google Scholar]
  36. Jugdutt B. I., Warnica J. W. Tolerance with low dose intravenous nitroglycerin therapy in acute myocardial infarction. Am J Cardiol. 1989 Sep 15;64(10):581–587. doi: 10.1016/0002-9149(89)90482-7. [DOI] [PubMed] [Google Scholar]
  37. Katz S. D., Schwarz M., Yuen J., LeJemtel T. H. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Circulation. 1993 Jul;88(1):55–61. doi: 10.1161/01.cir.88.1.55. [DOI] [PubMed] [Google Scholar]
  38. Keith R. A., Burkman A. M., Sokoloski T. D., Fertel R. H. Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle. J Pharmacol Exp Ther. 1982 Jun;221(3):525–531. [PubMed] [Google Scholar]
  39. Lange R. L., Reid M. S., Tresch D. D., Keelan M. H., Bernhard V. M., Coolidge G. Nonatheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure. Circulation. 1972 Oct;46(4):666–678. doi: 10.1161/01.cir.46.4.666. [DOI] [PubMed] [Google Scholar]
  40. Liew F. Y., Li Y., Severn A., Millott S., Schmidt J., Salter M., Moncada S. A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur J Immunol. 1991 Oct;21(10):2489–2494. doi: 10.1002/eji.1830211027. [DOI] [PubMed] [Google Scholar]
  41. Lüscher T. F., Vanhoutte P. M. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension. 1986 Apr;8(4):344–348. doi: 10.1161/01.hyp.8.4.344. [DOI] [PubMed] [Google Scholar]
  42. Mancini G. B., Henry G. C., Macaya C., O'Neill B. J., Pucillo A. L., Carere R. G., Wargovich T. J., Mudra H., Lüscher T. F., Klibaner M. I. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation. 1996 Aug 1;94(3):258–265. doi: 10.1161/01.cir.94.3.258. [DOI] [PubMed] [Google Scholar]
  43. Marsden P. A., Heng H. H., Scherer S. W., Stewart R. J., Hall A. V., Shi X. M., Tsui L. C., Schappert K. T. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993 Aug 15;268(23):17478–17488. [PubMed] [Google Scholar]
  44. McVeigh G. E., Brennan G. M., Johnston G. D., McDermott B. J., McGrath L. T., Henry W. R., Andrews J. W., Hayes J. R. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992 Aug;35(8):771–776. doi: 10.1007/BF00429099. [DOI] [PubMed] [Google Scholar]
  45. McVeigh G., Brennan G., Hayes R., Johnston D. Primary nitrate tolerance in diabetes mellitus. Diabetologia. 1994 Jan;37(1):115–117. doi: 10.1007/BF00428787. [DOI] [PubMed] [Google Scholar]
  46. Nadaud S., Bonnardeaux A., Lathrop M., Soubrier F. Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun. 1994 Feb 15;198(3):1027–1033. doi: 10.1006/bbrc.1994.1146. [DOI] [PubMed] [Google Scholar]
  47. Nakamura M., Funakoshi T., Arakawa N., Yoshida H., Makita S., Hiramori K. Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure. J Am Coll Cardiol. 1994 Nov 1;24(5):1321–1327. doi: 10.1016/0735-1097(94)90115-5. [DOI] [PubMed] [Google Scholar]
  48. Oyama Y., Kawasaki H., Hattori Y., Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol. 1986 Dec 2;132(1):75–78. doi: 10.1016/0014-2999(86)90013-0. [DOI] [PubMed] [Google Scholar]
  49. Packer M., Lee W. H., Kessler P. D., Gottlieb S. S., Medina N., Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med. 1987 Sep 24;317(13):799–804. doi: 10.1056/NEJM198709243171304. [DOI] [PubMed] [Google Scholar]
  50. Packer M., Medina N., Yushak M., Lee W. H. Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure. Am J Cardiol. 1986 Feb 1;57(4):260–267. doi: 10.1016/0002-9149(86)90902-1. [DOI] [PubMed] [Google Scholar]
  51. Palmer R. M., Ashton D. S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988 Jun 16;333(6174):664–666. doi: 10.1038/333664a0. [DOI] [PubMed] [Google Scholar]
  52. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11;327(6122):524–526. doi: 10.1038/327524a0. [DOI] [PubMed] [Google Scholar]
  53. Panza J. A., Quyyumi A. A., Brush J. E., Jr, Epstein S. E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990 Jul 5;323(1):22–27. doi: 10.1056/NEJM199007053230105. [DOI] [PubMed] [Google Scholar]
  54. Parker J. O., Farrell B., Lahey K. A., Moe G. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate. N Engl J Med. 1987 Jun 4;316(23):1440–1444. doi: 10.1056/NEJM198706043162303. [DOI] [PubMed] [Google Scholar]
  55. Parker J. O., Vankoughnett K. A., Farrell B. Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance in stable angina pectoris. Am J Cardiol. 1985 Nov 1;56(12):724–728. doi: 10.1016/0002-9149(85)91123-3. [DOI] [PubMed] [Google Scholar]
  56. Pepke-Zaba J., Higenbottam T. W., Dinh-Xuan A. T., Stone D., Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet. 1991 Nov 9;338(8776):1173–1174. doi: 10.1016/0140-6736(91)92033-x. [DOI] [PubMed] [Google Scholar]
  57. Plane F., Bruckdorfer K. R., Kerr P., Steuer A., Jacobs M. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta. Br J Pharmacol. 1992 Jan;105(1):216–222. doi: 10.1111/j.1476-5381.1992.tb14237.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Rajfer J., Aronson W. J., Bush P. A., Dorey F. J., Ignarro L. J. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med. 1992 Jan 9;326(2):90–94. doi: 10.1056/NEJM199201093260203. [DOI] [PubMed] [Google Scholar]
  59. Rossaint R., Falke K. J., López F., Slama K., Pison U., Zapol W. M. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993 Feb 11;328(6):399–405. doi: 10.1056/NEJM199302113280605. [DOI] [PubMed] [Google Scholar]
  60. Saenz de Tejada I., Goldstein I., Azadzoi K., Krane R. J., Cohen R. A. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med. 1989 Apr 20;320(16):1025–1030. doi: 10.1056/NEJM198904203201601. [DOI] [PubMed] [Google Scholar]
  61. Sawicki P. T., Heinemann L., Starke A., Berger M. Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma. Diabetologia. 1992 Jul;35(7):649–652. doi: 10.1007/BF00400257. [DOI] [PubMed] [Google Scholar]
  62. Schaberg T., Lauer C., Lode H., Fischer J., Haller H. Increased number of alveolar macrophages expressing adhesion molecules of the leukocyte adhesion molecule family in smoking subjects. Association with cell-binding ability and superoxide anion production. Am Rev Respir Dis. 1992 Nov;146(5 Pt 1):1287–1293. doi: 10.1164/ajrccm/146.5_Pt_1.1287. [DOI] [PubMed] [Google Scholar]
  63. Schmidt H. H., Warner T. D., Ishii K., Sheng H., Murad F. Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides. Science. 1992 Feb 7;255(5045):721–723. doi: 10.1126/science.1371193. [DOI] [PubMed] [Google Scholar]
  64. Sharpe N., Coxon R., Webster M., Luke R. Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure. Am J Cardiol. 1987 Apr 1;59(8):895–899. doi: 10.1016/0002-9149(87)91115-5. [DOI] [PubMed] [Google Scholar]
  65. Simionescu M., Simionescu N. Functions of the endothelial cell surface. Annu Rev Physiol. 1986;48:279–293. doi: 10.1146/annurev.ph.48.030186.001431. [DOI] [PubMed] [Google Scholar]
  66. Snyder S. H. Nitric oxide: first in a new class of neurotransmitters. Science. 1992 Jul 24;257(5069):494–496. doi: 10.1126/science.1353273. [DOI] [PubMed] [Google Scholar]
  67. Sprague R. S., Thiemermann C., Vane J. R. Endogenous endothelium-derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits. Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8711–8715. doi: 10.1073/pnas.89.18.8711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Springer T. A. The sensation and regulation of interactions with the extracellular environment: the cell biology of lymphocyte adhesion receptors. Annu Rev Cell Biol. 1990;6:359–402. doi: 10.1146/annurev.cb.06.110190.002043. [DOI] [PubMed] [Google Scholar]
  69. Stout R. W. Insulin as a mitogenic factor: role in the pathogenesis of cardiovascular disease. Am J Med. 1991 Feb 21;90(2A):62S–65S. doi: 10.1016/0002-9343(91)90041-u. [DOI] [PubMed] [Google Scholar]
  70. Strano A., Davì G., Patrono C. In vivo platelet activation in diabetes mellitus. Semin Thromb Hemost. 1991 Oct;17(4):422–425. doi: 10.1055/s-2007-1002648. [DOI] [PubMed] [Google Scholar]
  71. Taylor P. D., McCarthy A. L., Thomas C. R., Poston L. Endothelium-dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocin-induced diabetic rats. Br J Pharmacol. 1992 Oct;107(2):393–399. doi: 10.1111/j.1476-5381.1992.tb12757.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Taylor P. D., Poston L. The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery. Br J Pharmacol. 1994 Nov;113(3):801–808. doi: 10.1111/j.1476-5381.1994.tb17064.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Tesfamariam B., Cohen R. A. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol. 1992 Aug;263(2 Pt 2):H321–H326. doi: 10.1152/ajpheart.1992.263.2.H321. [DOI] [PubMed] [Google Scholar]
  74. Tesfamariam B., Palacino J. J., Weisbrod R. M., Cohen R. A. Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J Cardiovasc Pharmacol. 1993 Feb;21(2):205–211. doi: 10.1097/00005344-199302000-00004. [DOI] [PubMed] [Google Scholar]
  75. Thadani U., Hamilton S. F., Olson E., Anderson J., Voyles W., Prasad R., Teague S. M. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance. Ann Intern Med. 1986 Oct;105(4):485–492. doi: 10.7326/0003-4819-105-4-485. [DOI] [PubMed] [Google Scholar]
  76. Thiemermann C., Szabó C., Mitchell J. A., Vane J. R. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):267–271. doi: 10.1073/pnas.90.1.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Uitto J., Perejda A. J., Grant G. A., Rowold E. A., Kilo C., Williamson J. R. Glycosylation of human glomerular basement membrane collagen: increased content of hexose in ketoamine linkage and unaltered hydroxylysine-O-glycosides in patients with diabetes. Connect Tissue Res. 1982;10(3-4):287–296. doi: 10.3109/03008208209008054. [DOI] [PubMed] [Google Scholar]
  78. Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989 Oct 28;2(8670):997–1000. doi: 10.1016/s0140-6736(89)91013-1. [DOI] [PubMed] [Google Scholar]
  79. Vallance P., Moncada S. Role of endogenous nitric oxide in septic shock. New Horiz. 1993 Feb;1(1):77–86. [PubMed] [Google Scholar]
  80. Vanderwinden J. M., Mailleux P., Schiffmann S. N., Vanderhaeghen J. J., De Laet M. H. Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. N Engl J Med. 1992 Aug 20;327(8):511–515. doi: 10.1056/NEJM199208203270802. [DOI] [PubMed] [Google Scholar]
  81. Varriale P., David W. J., Chryssos B. E. Hemodynamic resistance to intravenous nitroglycerin in severe congestive heart failure and restored response after diuresis. Am J Cardiol. 1991 Nov 15;68(13):1400–1402. doi: 10.1016/0002-9149(91)90254-i. [DOI] [PubMed] [Google Scholar]
  82. Wohaieb S. A., Godin D. V. Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment. Diabetes. 1987 Sep;36(9):1014–1018. doi: 10.2337/diab.36.9.1014. [DOI] [PubMed] [Google Scholar]
  83. Wright C. E., Rees D. D., Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res. 1992 Jan;26(1):48–57. doi: 10.1093/cvr/26.1.48. [DOI] [PubMed] [Google Scholar]
  84. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  85. Zeiher A. M., Krause T., Schächinger V., Minners J., Moser E. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation. 1995 May 1;91(9):2345–2352. doi: 10.1161/01.cir.91.9.2345. [DOI] [PubMed] [Google Scholar]
  86. de Belder A. J., MacAllister R., Radomski M. W., Moncada S., Vallance P. J. Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. Cardiovasc Res. 1994 May;28(5):691–694. doi: 10.1093/cvr/28.5.691. [DOI] [PubMed] [Google Scholar]

Articles from The Ulster Medical Journal are provided here courtesy of Ulster Medical Society

RESOURCES